Outlook Therapeutics
OTLK
OTLK
15 hedge funds and large institutions have $3.32M invested in Outlook Therapeutics in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $4.96M → $3.32M (-$1.64M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$30K | |
| 2 | +$25.8K | |
| 3 | +$6.54K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.11K |
Top Sellers
| 1 | -$40K | |
| 2 | -$37K | |
| 3 | -$32K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$28.1K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$24K |